cantab testimonial

Speech based biomarkers for monitoring progressive changes in Alzheimer’s disease

A speech based composite which tracks change in AD over time was recently developed and piloted through a collaboration between Winterlight Labs and Genentech.

Speech is a rich source of clinical information when assessing and monitoring Alzheimer’s Disease. Natural language processing technologies, like those developed by Winterlight Labs, can objectively quantify speech and enable its use as a novel endpoint in drug development.

The next generation of treatments for Alzheimer’s Disease in clinical trials

The latest advances in the treatment of Alzheimer’s disease and how Cambridge Cognition are designing and implementing empirically validated and clinically-relevant cognitive tasks to help develop the next generation of Alzheimer’s disease treatments. 

There are presently over 140 drugs being explored as possible treatments for Alzheimer’s Disease (AD) in clinical trials. Of these, nearly 80% are intended to slow the progression of AD. Historically, cholinesterase inhibitor drugs such as galantamine, rivastigmine and donepezil have been approved for treatment of AD. These drugs have been shown to mitigate symptoms of AD, such as memory loss, however they are unable to treat the underlying neurobiological cause of the condition. As such, these drugs do not slow AD progression and are not considered a long-term solution in the battle to end the most common form of neurodegenerative disease.

Using a multidisciplinary approach to characterise the neurobiology of addiction

Insights Back to resource centre 6 October 2022 Understanding the effect of ashwagandha root extract on stress, sleep and cognition We caught up with Shefali Thanawala from Nutriventia Ltd who told us how CANTAB™ helped them to investigate the effects of Ashwagandha root extract on memory and focus in healthy, stressed adults. About Nutriventia, Ltd.Nutriventia Limited is the dietary supplements

Team members from University of Sinagpore

Measuring cognition in areas outside of the Central Nervous System

Insights Back to resource centre 24 April 2023 Measuring cognition in areas outside of the Central Nervous System CANTAB® cognitive assessments are often used to measure cognition in disorders of the Central Nervous System, but did you know that they are also used in research that don’t involve the CNS? Here, two research teams explain how CANTAB is supporting their

Picture of Anders Aasheim

Using CANTAB to understand more about depth of anaesthesia and post-operative cognitive dysfunction

Insights Back to resource centre 21 March 2023 Using CANTAB to understand more about depth of anaesthesia and post-operative cognitive dysfunction We caught up with Anders Aasheim from Oslo University Hospital who told us more about his team’s research in understanding the effect of anaesthesia on cognitive function. My name is Anders Aasheim, and I am a nurse anaesthetist and

The role of cognitive functions in the diagnosis of bipolar disorder: A machine learning model

Insights Back to resource centre 1 February 2023 The role of cognitive functions in the diagnosis of bipolar disorder: A machine learning model We caught up with Ercan Altınöz, Associate Professor of Psychiatry at Eskişehir Osmangazi University School of Medicine in Eskişehir, Turkey, who told us how combining CANTAB® tasks with machine learning may help to improve diagnosis of bipolar

Using CANTAB to assess cognitive function in long-term Hodgkin lymphoma survivors

Insights Back to resource centre 6 January 2023 Using CANTAB to assess cognitive function in long-term Hodgkin lymphoma survivors We caught up with Dr Ferenc Magyari from the University of Debrecen, who told us how CANTAB™ has helped them to understand the long-term cognitive impact of Hodgkin’s Lymphoma. I started working as an internal medicine resident doctor at the University

Understanding the effect of ashwagandha root extract on stress, sleep and cognition

Insights Back to resource centre 6 October 2022 Understanding the effect of ashwagandha root extract on stress, sleep and cognition We caught up with Shefali Thanawala from Nutriventia Ltd who told us how CANTAB™ helped them to investigate the effects of Ashwagandha root extract on memory and focus in healthy, stressed adults. About Nutriventia, Ltd.Nutriventia Limited is the dietary supplements

Using CANTAB to develop AI-based tools for the early detection of dementia

Insights Back to resource centre 21 September 2022 Using CANTAB to develop AI-based tools for the early detection of dementia To mark World Alzheimer’s Day, we hear from Christoffer Hatlestad-Hall and his team at Oslo University Hospital, who explain how CANTABTM is an instrumental part of their study using AI and machine learning to identify the earliest signs of Alzheimer’s

Developing a method of delivering experimenter-led online cognitive assessments

Insights Back to resource centre 6 October 2022 Understanding the effect of ashwagandha root extract on stress, sleep and cognition We caught up with Shefali Thanawala from Nutriventia Ltd who told us how CANTAB™ helped them to investigate the effects of Ashwagandha root extract on memory and focus in healthy, stressed adults. About Nutriventia, Ltd.Nutriventia Limited is the dietary supplements

Scroll to Top